ALAlphabet Inc.

Institutional investor · Portfolio as of Q4 2020

Top Holdings31 positions

Checking export access…
Activity:

LYFT INC

11.6M$568.5M27.3%$40.84+20.30%
6 qtrssince 2019-Q3
Decreased
0

DEXCOM INC

805,681$297.9M14.3%$52.30+76.72%
6 qtrssince 2019-Q3
Unchanged
0
DMDMDelisted

Desktop Metal Inc

14.3M$246M11.8%——
1 qtr
New
96

TWILIO INC

475,859$161.1M7.7%$338.500.00%
1 qtr
New
95

ARCUS BIOSCIENCES INC

5M$131.1M6.3%$9.10+185.27%
6 qtrssince 2019-Q3
Unchanged
0

AIRBNB INC

691,612$101.5M4.9%$146.800.00%
1 qtr
New
84

LEMONADE INC

824,743$101M4.8%$49.72+146.38%
2 qtrssince 2020-Q3
Unchanged
0

RELAY THERAPEUTICS INC

1.8M$74.9M3.6%$42.59-2.42%
2 qtrssince 2020-Q3
Unchanged
0
WORKWORKDelisted

Slack Technologies Inc.

1.3M$54.9M2.6%——
6 qtrssince 2019-Q3
Unchanged
0

BEAM THERAPEUTICS INC

663,691$54.2M2.6%$18.00+353.56%
4 qtrssince 2020-Q1
Unchanged
0
KRONKRONDelisted

KRONOS BIO INC

1.4M$43M2.1%——
1 qtr
New
76

UPSTART HLDGS INC

832,423$33.9M1.6%$40.750.00%
1 qtr
New
67

OPENDOOR TECHNOLOGIES INC

1.3M$28.4M1.4%$22.730.00%
1 qtr
New
67
3.3M$26.2M1.3%——
6 qtrssince 2019-Q3
Unchanged
0
SQSQZBDelisted

SQZ Biotechnologies Co

831,389$24.1M1.2%——
1 qtr
New
66

SPERO THERAPEUTICS INC

889,979$17.3M0.8%$10.60+82.92%
6 qtrssince 2019-Q3
Decreased
0

TAYSHA GENE THERAPIES INC

640,882$17M0.8%$22.40+18.48%
2 qtrssince 2020-Q3
Unchanged
0
RAPTRAPTDelisted

RAPT THERAPEUTICS INC

831,254$16.4M0.8%——
5 qtrssince 2019-Q4
Decreased
0
EVLOEVLODelisted

Evelo Biosciences Inc

1.1M$12.8M0.6%——
6 qtrssince 2019-Q3
Unchanged
0

IDEAYA BIOSCIENCES INC

753,187$10.5M0.5%$9.00+55.56%
6 qtrssince 2019-Q3
Unchanged
0
$2.1B
AUM
31
Positions
Q4 2020
Filing
HI score · 2.5/5
Quarterly 13F Value Change
-50%Q4'19$1.7B-8%Q1'20$1.5B+42%Q2'20$2.2B-2%Q3'20$2.1B-2%Q4'20$2.1B
Activity profile
$ moved · Q4'20
New34%Increased0%Decreased12%Exited54%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.1 quarters
<1Q29%1-4Q13%1-2Y58%2Y+0%

Alphabet Inc. manages $2.1B across 31 positions as of Q4 2020. Top holdings: LYFT (27.3%), DXCM (14.3%), DM (11.8%). Fund DNA: Concentrated Value. HoldingsIntel Score: 2.5/5.0.

Q4 2020 Summary

Active quarter - 9 new positions, 2 exits, 1 increased. Top move: DM (NEW, conviction 96). Portfolio: $2.1B across 31 positions.

Top holdings by portfolio weight

Total AUM$2B
LYFT27.27%
DXCM14.29%
DM11.80%
TWLO7.73%
RCUS6.29%
ABNB4.87%
LMND4.85%
RLAY3.59%
WORK2.63%
BEAM2.60%
Other2.06%

Portfolio allocation by GICS sector

Sectors6
Technology35.90%
Healthcare33.45%
Unknown17.78%
Financial Services6.56%
Consumer Cyclical4.93%
Real Estate1.38%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Technology, Healthcare, Unknown
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(2.5 / 5.0)
Holdings P&L48
Conviction36
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used